[Hypoglycemia in glibenclamide therapy in diabetes]

Motor imagery and self-recognition from actions.

NeuroImage·2025

Handling Kinematic Features in an Action Observation Task to Optimize a Brain Computer Interface-Based Rehabilitation Training.

IEEE ... International Conference on Rehabilitation Robotics : [proceedings]·2025

Robot-assisted uretero-ureterostomy.

Journal of pediatric urology·2025

The localization and function of the moonlighting protein Clathrin during oocyte maturation.

Developmental biology·2024

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Diverging conformations guide dipeptide self-assembly into crystals or hydrogels.

Chemical communications (Cambridge, England)·2023

[Switch from STEMI to OMI].

Lakartidningen·2026

[Maxillomandibular advancement].

Lakartidningen·2026

[Same day discharge robotic-assisted radical prostatectomy (RARP) - time for a shift in paradigm?]

Lakartidningen·2026

[Reporting of clinical trials].

Lakartidningen·2026

[Hybrid warfare - a complex threat to Swedish health care].

Lakartidningen·2026

[Virtually planned correction of a forearm malunion with 3D-technology, a case presentation].

Lakartidningen·2026

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Cureus·2026

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Frontiers in endocrinology·2026

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Canadian journal of kidney health and disease·2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Frontiers in pharmacology·2026

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Frontiers in molecular neuroscience·2026

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Therapeutic advances in neurological disorders·2026

Related Experiment Videos

[Hypoglycemia in glibenclamide therapy in diabetes]

Related Concept Videos

Motor imagery and self-recognition from actions.

Handling Kinematic Features in an Action Observation Task to Optimize a Brain Computer Interface-Based Rehabilitation Training.

Robot-assisted uretero-ureterostomy.

The localization and function of the moonlighting protein Clathrin during oocyte maturation.

Early prediction of endocrine responsiveness in ER+/HER2-negative metastatic breast cancer (MBC): pilot study with 18F-fluoroestradiol (18F-FES) CT/PET.

Diverging conformations guide dipeptide self-assembly into crystals or hydrogels.

[Switch from STEMI to OMI].

[Maxillomandibular advancement].

[Same day discharge robotic-assisted radical prostatectomy (RARP) - time for a shift in paradigm?]

[Reporting of clinical trials].

[Hybrid warfare - a complex threat to Swedish health care].

[Virtually planned correction of a forearm malunion with 3D-technology, a case presentation].

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization.

Glucagon-like peptide-1 and peptide YY multi-agonism with GEP44 to optimize weight loss and glycemic control while reducing gastrointestinal side effects: the future of anti-obesity pharmacotherapy?

Validation of a Pharmacist-Led Semaglutide Prescribing Algorithm for Type 2 Diabetes and Chronic Kidney Disease: Research Letter.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Dynamic structural profiling of PINK1 mutations (T313M and L347P) reveals a vital molecular perturbation namely phospho-Serine 65 ubiquitin recognition point in mitophagy mediated autosomal recessive Parkinson's disease (ARPD).

Real-world siponimod use in secondary progressive multiple sclerosis: the RESYZE study.

Related Experiment Videos

[Hypoglycemia in glibenclamide therapy in diabetes]

Related Concept Videos

Related Articles